We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LULU:ADXLulu Retail Holdings PLC Analysis

Data as of 2026-09-09 - not real-time

$99.72

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind lululemon athletica inc. is bearish at $99.72, with short-term averages lagging the long-term ones. It has lost 17.1% over the past 30 days. With RSI at 32.8 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $97.55 as support and $124.95 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 8.2 with no clean sector comparison available. Consensus targets land 7.7% above where the shares trade now. Revenue is contracting at 4.3% on a 12.8% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 67.2%, a beta of 1.24 and a maximum drawdown of 53.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

・Ranju Das joined in September as Lululemon’s first AI chief, focusing on technology to boost efficiency and...Despite a dip in North American sales, Lululemon Athletica Inc LULU sees promising growth in China and focuses on...Seeking Alpha1monLululemon cut to ‘sell’ at Truist on downside risks, weak trendsTruist Securities downgraded...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 152.13
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 152.13
  • Analyst targets imply +7.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +7.7% versus the current price
  • Revenue contracting at -4.3%
  • P/E ratio of 8.2

Key Metrics & Analysis

Financial Health

Revenue Growth-4.30%
Profit Margin12.78%
P/E Ratio8.2
ROE30.90%
ROA14.40%
Debt/Equity44.69
P/B Ratio2.4
Op. Cash Flow$2.0B
Free Cash Flow$1.1B

Technical Analysis

TrendBearish
RSI32.8
Support$97.55
Resistance$124.95
MA 20$116.39
MA 50$117.82
MA 200$152.13
MACDBearish
VolumeIncreasing
Fear & Greed Index92.04

Valuation

Fair Value$124.01
Target Price$107.43
Upside/Downside7.73%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.24
Volatility67.23%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.